SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-056770
Filing Date
2023-11-28
Accepted
2023-11-28 16:14:34
Documents
2
Period of Report
2023-11-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10253
2 POA DOCUMENT poa.txt EX-24 3671
  Complete submission text file 0001209191-23-056770.txt   15375
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SANGAMO THERAPEUTICS, INC. 7000 MARINA BLVD. BRISBANE CA 94005
Business Address
Pooler Amy (Reporting) CIK: 0002001413 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30171 | Film No.: 231446560